Halozyme Therapeutics Inc (HALO)
40.37
-0.49
(-1.20%)
USD |
NASDAQ |
Mar 18, 16:00
40.38
+0.01
(+0.02%)
Pre-Market: 09:27
Halozyme Therapeutics Market Cap: 5.120B for March 18, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 18, 2024 | 5.120B |
March 15, 2024 | 5.182B |
March 14, 2024 | 5.173B |
March 13, 2024 | 5.244B |
March 12, 2024 | 5.320B |
March 11, 2024 | 5.225B |
March 08, 2024 | 5.292B |
March 07, 2024 | 5.290B |
March 06, 2024 | 5.287B |
March 05, 2024 | 5.252B |
March 04, 2024 | 5.191B |
March 01, 2024 | 5.214B |
February 29, 2024 | 5.049B |
February 28, 2024 | 5.034B |
February 27, 2024 | 5.053B |
February 26, 2024 | 5.031B |
February 23, 2024 | 5.144B |
February 22, 2024 | 5.037B |
February 21, 2024 | 4.865B |
February 20, 2024 | 4.566B |
February 16, 2024 | 4.578B |
February 15, 2024 | 4.554B |
February 14, 2024 | 4.446B |
February 13, 2024 | 4.393B |
February 12, 2024 | 4.526B |
Date | Value |
---|---|
February 09, 2024 | 4.499B |
February 08, 2024 | 4.467B |
February 07, 2024 | 4.476B |
February 06, 2024 | 4.439B |
February 05, 2024 | 4.270B |
February 02, 2024 | 4.270B |
February 01, 2024 | 4.343B |
January 31, 2024 | 4.291B |
January 30, 2024 | 4.281B |
January 29, 2024 | 4.362B |
January 26, 2024 | 4.337B |
January 25, 2024 | 4.375B |
January 24, 2024 | 4.443B |
January 23, 2024 | 4.405B |
January 22, 2024 | 4.311B |
January 19, 2024 | 4.329B |
January 18, 2024 | 4.428B |
January 17, 2024 | 4.569B |
January 16, 2024 | 4.609B |
January 12, 2024 | 4.365B |
January 11, 2024 | 4.314B |
January 10, 2024 | 4.390B |
January 09, 2024 | 4.436B |
January 08, 2024 | 4.502B |
January 05, 2024 | 4.452B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.919B
Minimum
Mar 18 2020
8.037B
Maximum
Dec 02 2022
4.740B
Average
5.031B
Median
Jan 11 2022
Market Cap Benchmarks
Johnson & Johnson | 377.60B |
Globus Medical Inc | 6.992B |
AIM ImmunoTech Inc | 18.32M |
Protalix BioTherapeutics Inc | 92.78M |
Armata Pharmaceuticals Inc | 124.34M |
Market Cap Related Metrics
PE Ratio | 19.13 |
PS Ratio | 6.531 |
PEG Ratio | 0.4203 |
Price to Book Value | 61.09 |
Price to Free Cash Flow | 14.51 |
Price | 40.37 |
Earnings Yield | 5.23% |
PEGY Ratio | 0.4203 |
Operating PE Ratio | 16.04 |
Normalized PE Ratio | 20.89 |